Company / FCF Margin
Emergent BioSolutions Inc. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
21.1%
FY2025
5-year range
-24.6% / 21.1%
FY2021-FY2025
Trend
+515.5%
vs FY2024
Sector context
#27 of 134
Health Care
What the data says
FCF Margin changed +515% YoY in FY2025, a notable deviation from the 9-year average annual change of +134%.
Based on SEC 10-K filings.
21.1% in FY2025 with a 5-year CAGR of -4.3%. Top quartile in the Health Care sector.
Improved from -24.6% to 21.1% over the past 2 years.
Health Care sector context is included.
FCF Margin over time
Growth rates
- 3-Year Change
- +34.5pp
- 5-Year Change
- -4.3pp
- 10-Year Change
- -
Sector benchmark
Top 20% in Health CareTop 20% of 134This company 21.1% Sector average -637.8%
▼
+103.3% above sector average
Key checks
Key Insights
- In FY2025, fcf margin increased 515.5% year-over-year.
- Currently 658.9pp above the Health Care sector average.
- Peak fcf margin was recorded in FY2017.
- Lowest fcf margin in the period was in FY2023.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 21.1% | +515.5% |
| FY2024 | 3.4% | +114.0% |
| FY2023 | -24.6% | -83.3% |
| FY2022 | -13.4% | -347.4% |
| FY2021 | 5.4% | -78.7% |
| FY2020 | 25.4% | +177.9% |
| FY2019 | 9.1% | +306.8% |
| FY2018 | -4.4% | -116.2% |
| FY2017 | 27.3% | +718.3% |
| FY2016 | -4.4% | -904.5% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026